Paraneoplastic orthostatic hypotension associated with acute myeloid leukemia
被引:0
|
作者:
Lee, S.
论文数: 0引用数: 0
h-index: 0
机构:
Icahn Sch Med Mt Sinai, Elmhurst Hosp Ctr, Dept Med, Elmhurst, NY USAIcahn Sch Med Mt Sinai, Elmhurst Hosp Ctr, Dept Med, Elmhurst, NY USA
Lee, S.
[1
]
Chary, M.
论文数: 0引用数: 0
h-index: 0
机构:
Icahn Sch Med Mt Sinai, New York, NY 10029 USAIcahn Sch Med Mt Sinai, Elmhurst Hosp Ctr, Dept Med, Elmhurst, NY USA
Chary, M.
[2
]
Petersen, B.
论文数: 0引用数: 0
h-index: 0
机构:
Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USAIcahn Sch Med Mt Sinai, Elmhurst Hosp Ctr, Dept Med, Elmhurst, NY USA
Petersen, B.
[3
]
Mascarenhas, J. O.
论文数: 0引用数: 0
h-index: 0
机构:
Icahn Sch Med Mt Sinai, Div Hematol & Oncol, Tisch Canc Inst, New York, NY 10029 USAIcahn Sch Med Mt Sinai, Elmhurst Hosp Ctr, Dept Med, Elmhurst, NY USA
Mascarenhas, J. O.
[4
]
机构:
[1] Icahn Sch Med Mt Sinai, Elmhurst Hosp Ctr, Dept Med, Elmhurst, NY USA
[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[3] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA
[4] Icahn Sch Med Mt Sinai, Div Hematol & Oncol, Tisch Canc Inst, New York, NY 10029 USA
Paraneoplastic neuropathies associated with leukemia are rare, and early diagnosis and treatment are crucial due to the potential for irreversible neurological deficits and delay in treatment of the leukemia. This is the first report to describe severe paraneoplastic orthostatic hypotension which resolved after treatment of the acute myeloid leukemia (AML). The patient is a 76 year-old woman who presented with progressive dizziness, anorexia, and fatigue. She had severe orthostatic hypotension (supine systolic blood pressure 186 mmHg and standing 79 mmHg). She was found to have AML, for which azacitidine was initiated, and orthostatic hypotension resolved after initiation of treatment. This case demonstrates a unique example of paraneoplastic sequelae remitting with treatment of the underlying hematologic neoplasm. Physicians should be aware of this unusual occurrence of autonomic neuropathy with AML as delay in treatment of the hematologic malignancy can lead to irreversible neurologic deficit and increased morbidity and mortality.
机构:
Harvard Univ, Dept Neurol, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USAHarvard Univ, Dept Neurol, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA